Sign In
Buy AZN
$183.02
+2.00 (+1.10%)
At Close: Jun 24, 2026
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, fol
AstraZeneca (AZN) Reels from China Investigation and Investor Suit– Hagens Berman
02:47pm, Monday, 06'th Jan 2025
SAN FRANCISCO, Jan. 06, 2025 (GLOBE NEWSWIRE) -- AstraZeneca (NASDAQ: AZN), the Anglo-Swedish pharmaceutical giant, has seen its stock price tumble 15 percent over the past six months, buffeted by a s
Shareholders that lost money on AstraZeneca PLC(AZN) should contact Levi & Korsinsky about pending Class Action - AZN
02:00pm, Monday, 06'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, Jan. 06, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of AstraZeneca PLC (NASDAQ: AZN) between February 23, 2022 and Dec
Law Offices of Frank R. Cruz Encourages AstraZeneca PLC (AZN) Investors To Inquire About Securities Fraud Class Action
12:06pm, Monday, 06'th Jan 2025
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Encourages AstraZeneca PLC (AZN) Investors To Inquire About Securities Fraud Class Action.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 21, 2025 in AstraZeneca Lawsuit - AZN
11:30am, Monday, 06'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, fol
AstraZeneca PLC Is Being Sued For Securities Law Violations And The Schall Law Firm Urges Impacted Shareholders To Reach Out
11:15am, Monday, 06'th Jan 2025
LOS ANGELES, CA / ACCESSWIRE / January 6, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca"
The Law Offices of Frank R. Cruz Continues Its Investigation of AstraZeneca PLC (AZN) on Behalf of Investors
11:05am, Monday, 06'th Jan 2025
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Continues Its Investigation of AstraZeneca PLC (AZN) on Behalf of Investors.
Contact Levi & Korsinsky by February 21, 2025 Deadline to Join Class Action Against AstraZeneca PLC (AZN)
11:00am, Monday, 06'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NASDAQ:AZN). Such investors are advised
AZN Investors Have Opportunity to Lead AstraZeneca PLC Securities Fraud Lawsuit with the Schall Law Firm
10:50am, Monday, 06'th Jan 2025
LOS ANGELES , Jan. 6, 2025 /PRNewswire/ -- The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against AstraZeneca PLC ("AstraZeneca" or "
AstraZeneca Stock Down Almost 14% in 3 Months: Time to Sell?
09:56am, Monday, 06'th Jan 2025
AZN's key drugs like Lynparza, Tagrisso, Imfinzi, Ultomiris and Fasenra are likely to drive sales. It has several candidates with blockbuster potential.
Class Action Filed Against AstraZeneca PLC (AZN) Seeking Recovery for Investors - Contact Levi & Korsinsky
07:30am, Monday, 06'th Jan 2025
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / If you suffered a loss on your AstraZeneca PLC (NASDAQ:AZN) investment and want to learn about a potential recovery under the federal securities laws, fol
NEW YORK, NY / ACCESSWIRE / January 6, 2025 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against AstraZeneca PL
